香港股市 已收市

MRK Jun 2024 140.000 call

OPR - OPR 延遲價格。貨幣為 USD。
加入追蹤清單
0.01000.0000 (0.00%)
市場開市。 截至 12:14PM EDT。
全螢幕
前收市價0.0100
開市0.0100
買盤0.0000
賣出價0.0100
拍板140.00
到期日2024-06-21
今日波幅0.0100 - 0.0100
合同範圍
成交量4
未平倉合約3.93k
  • Yahoo Finance Video

    The 30-stock secret: ‘Don’t fight Papa Dow’

    JC Parets, founder and chief strategist at All Star Charts, explains why fighting the Dow Breadth is futile and how embracing the approach can simplify your market analysis significantly.   He spoke with Yahoo Finance’s Jared Blikre and Sydnee Fried on "Stocks in Translation." Listen to the full episode here, or wherever you get your podcasts. This post was written by Jared Blikre

  • Benzinga

    Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment

    AstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug Administration for its blockbuster cancer drug Imfinzi combined with chemotherapy being used as a treatment forpatients suffering from specific type of endometrial cancer. Its pharma peer, BioNTech SE (NASDAQ: BNTX) wasn’t as lucky as also on Monday, the FDA put its experimental cancer drug study on partial clinical hold. Combining Immunotherapy And Chemotherapy Is Emerging As A New Standard In Ca

  • Zacks

    Merck's (MRK) 21-Valent Pneumococcal Jab Gets FDA Approval

    Merck's (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive/V116, becomes the first PCV specifically designed for adults to be approved by the FDA.